Your industry news - first Number 1 for Recruitment
We strongly recommend viewing Cleanzine full size in your web browser. Click our masthead above to visit our website version.
Deal secures use of coating effective against SARS-COV-2 for global transportation industry
Millions of people rely on public transport infrastructure every day and it will be crucial to the opening of economies after Covid-19 lockdowns around the world. Yet many viruses and bacteria, including the SARS-COV-2 virus, can survive for up to three days on some surfaces, meaning regularly touched areas in public spaces have the potential to be cross contamination hotspots.
Help is at hand thanks to a deal between Finnish company Affix Labs and seat manufacturer Franz Kiel GmbH.
The deal means that Affix Labs' durable semi-permanent surface coating Si-Quat, which is proven to kill 99.9% of bacteria and viruses, including SARS-COV-2, will be helping to make public transport safer as people around the world begin getting back onto buses and trains.
Si-Quat helps prevent cross contamination with a durable layer of polymerised active ingredient that binds to walls, handles, furniture and other key touch points, staying in place for up to 12 months and killing 99.9% of viruses and bacteria that come into contact with the treated surface. The coating has been tested and certified to be effective against bacteria, viruses, and fungi, and has passed the rigorous EN45545-2 HL3 flammability norm for trains and REG118.3 for busses.
Kiel has been manufacturing high quality seating for public transport globally for more than 75 years and will now be offering Si-Quat to clients as a new solution to protect travellers on their transport networks. With Si-Quat already registered on several continents a quick roll out is truly achievable.
"We are delighted to be working with Affix Labs to roll out Si-Quat in public transport systems around the world," says Daniel Fräde, Kiel's sales director Bus Division. "It's easy to apply, it works and we have had great support from the Affix-Labs team. We hope that our partnership can help to reopen countries and boost passengers' trust in once again using public transport.
"By treating the vast fleets of vehicles that power the mass movement of people in countries all over the world, Affix and Kiel Seating can create safe transportation interiors which are a key component of national infrastructures."
Tom Sam, CEO of AFFIX Labs adds: "We are proud to be part of the global effort to build a more future-proof response to COVID-19, and other contagions that have the potential to cause pandemics."
6th May 2021